By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Idorsia 



Allschwil      Switzerland
Phone: n/a Fax: n/a


SEARCH JOBS

Idorsia will be an independent biopharmaceutical company specialized in the discovery and development of small molecules to meet significant unmet medical needs. Idorsia will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. Idorsia will inherit Actelion's established and validated drug discovery engine and a strong cross-section of its development organization. Idorsia's pipeline will continue to be developed by selected members of Actelion's development organization who joined Idorsia.

YEAR FOUNDED:

2017

LEADERSHIP:

CEO: Jean-Paul Clozel


Key Statistics


Email:
Ownership: Private

Web Site: Idorsia
Employees:
Symbol: 
 









Company News
//-->